Subscribe

Virinchi Limited (VIRINCHI.NS)

INR15.40 -0.39 (-2.47%)
IN NSE Technology Software - Application
Address 8-2-672/ 5&6, IIyas Mohammed Khan Estate 500034
Hyderabad, IN
CEO Amar Sivaji Pendyala
Website corporate.virinchi.com
IPO 2023-05-03
ISIN INE539B01017

Explore sections of this company profile

Also trades on Bombay Stock Exchange · VIRINCHI.BO (INR) National Stock Exchange of India · VIRINCHI.NS (INR)
Description

Headquartered in Hyderabad, India, Virinchi Limited, established in 1990, is a global provider of information technology products and services. The company's activities span three primary segments: software development and services, IT-enabled services, and healthcare. Its IT offerings include QFund, a specialized solution for the short-term mortgage and lending industry; vCard, a credit card powered by UPI technology; and V23, a comprehensive platform for healthcare practice management and patient engagement. Virinchi also delivers a wide array of IT services such as lifecycle management, enterprise content management (ECM), IT infrastructure management, staff augmentation, consulting, software development, and data science analysis. Beyond its core IT focus, the company serves diverse sectors including media and entertainment, catering, education, infrastructure, pharmacy supply chains, fintech, general healthcare, financial consulting, and short-term lending. Demonstrating a strong commitment to healthcare, Virinchi owns and operates both Virinchi multi-specialty hospitals and Bristlecone Hospitals. The company adopted its present name in January 2016, having previously operated as Virinchi Technologies Limited.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR15.40 -0.39 (-2.47%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
90.1K
Beta
0.71
Float Shares
58.21M
Free Float %
53.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-4.95% +6.07% -3.41% -12.28% -28.44% -25.41% -28.55% -49.22% -52.30% -52.30% -52.30%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
15.40
DCF (Unlevered) 8.69 -43.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
0.82
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Software - Application: +13.0%
    -5.6% Q1'26: -4.3% (vs Q1'25)
  • ✗
    EPS growth Software - Application: +28.6%
    -3,644.3% Q1'26: -220.9% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Software - Application: +45.3%
    -6.0% Q1'26: +3.4% (vs Q1'25)
  • ✗
    EBIT margin Software - Application: +9.4%
    +4.8% Q1'26: -9.8% (vs Q1'25)
  • ✗
    ROIC Software - Application: +7.5%
    +1.8% Q1'26: -2.9% (vs Q1'25)
  • ✗
    Share dilution Software - Application: +0.0%
    +1.7% Q1'26: +3.9% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×
    3.92× Q1'26: 9.19× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.34) × ERP
WACC = 40% × Ke + 60% × Kd (12.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 8.69 Current price: 15.40
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2024
actual 		Mar 2025
actual 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana. 		Mar 2029
1 Rev. Ana.
1 EPS Ana. 		Mar 2030
1 Rev. Ana.
1 EPS Ana. 		Mar 2031
1 Rev. Ana.
1 EPS Ana. 		Mar 2032
1 Rev. Ana.
1 EPS Ana. 		Mar 2033
1 Rev. Ana.
1 EPS Ana. 		Mar 2034
1 Rev. Ana.
1 EPS Ana. 		Mar 2035
1 Rev. Ana.
1 EPS Ana.
Revenue
3.00B
est: 5.31B (-43.5%)
3.01B
est: 6.42B (-53.1%)
2.88B
2.88B – 2.88B
-55.1% YoY
3.44B
3.44B – 3.44B
+19.4% YoY
3.96B
3.96B – 3.96B
+15.1% YoY
4.57B
4.57B – 4.57B
+15.5% YoY
2.93B
2.93B – 2.93B
-35.9% YoY
3.33B
3.33B – 3.33B
+13.3% YoY
3.73B
3.73B – 3.73B
+12.3% YoY
5.31B
5.31B – 5.31B
+42.3% YoY
6.42B
6.42B – 6.42B
+20.8% YoY
EBITDA
1.14B
est: 2.10B (-45.6%)
963.86M
est: 2.03B (-52.6%)
913.30M
913.30M – 913.30M
-55.1% YoY
1.09B
1.09B – 1.09B
+19.4% YoY
1.26B
1.26B – 1.26B
+15.1% YoY
1.45B
1.45B – 1.45B
+15.5% YoY
929.91M
929.91M – 929.91M
-35.9% YoY
1.05B
1.05B – 1.05B
+13.3% YoY
1.18B
1.18B – 1.18B
+12.3% YoY
1.68B
1.68B – 1.68B
+42.3% YoY
2.03B
2.03B – 2.03B
+20.8% YoY
EBIT
601.19M
est: 783.88M (-23.3%)
414.00M
est: 916.25M (-54.8%)
411.26M
411.26M – 411.26M
-55.1% YoY
490.87M
490.87M – 490.87M
+19.4% YoY
565.23M
565.23M – 565.23M
+15.1% YoY
652.84M
652.84M – 652.84M
+15.5% YoY
418.74M
418.74M – 418.74M
-35.9% YoY
474.54M
474.54M – 474.54M
+13.3% YoY
532.77M
532.77M – 532.77M
+12.3% YoY
758.26M
758.26M – 758.26M
+42.3% YoY
916.25M
916.25M – 916.25M
+20.8% YoY
Net Income
137.03M
est: 326.03M (-58.0%)
7.24M
est: 559.65M (-98.7%)
578.30M
578.30M – 578.30M
+3.3% YoY
620.27M
620.27M – 620.27M
+7.3% YoY
714.58M
714.58M – 714.58M
+15.2% YoY
835.84M
835.84M – 835.84M
+17.0% YoY
445.64M
445.64M – 445.64M
-46.7% YoY
590.74M
590.74M – 590.74M
+32.6% YoY
684.01M
684.01M – 684.01M
+15.8% YoY
331.64M
331.64M – 331.64M
-51.5% YoY
559.65M
559.65M – 559.65M
+68.7% YoY
SGA
770.45M
est: 1.65B (-53.3%)
1.01B
est: 2.01B (-49.9%)
904.07M
904.07M – 904.07M
-55.1% YoY
1.08B
1.08B – 1.08B
+19.4% YoY
1.24B
1.24B – 1.24B
+15.1% YoY
1.44B
1.44B – 1.44B
+15.5% YoY
920.51M
920.51M – 920.51M
-35.9% YoY
1.04B
1.04B – 1.04B
+13.3% YoY
1.17B
1.17B – 1.17B
+12.3% YoY
1.67B
1.67B – 1.67B
+42.3% YoY
2.01B
2.01B – 2.01B
+20.8% YoY
EPS
1.53
est: 3.20 (-52.2%)
0.07
est: 5.40 (-98.6%)
5.58
5.58 – 5.58
+3.3% YoY
5.99
5.99 – 5.99
+7.3% YoY
6.90
6.90 – 6.90
+15.2% YoY
8.07
8.07 – 8.07
+17.0% YoY
4.30
4.30 – 4.30
-46.7% YoY
5.70
5.70 – 5.70
+32.6% YoY
6.60
6.60 – 6.60
+15.8% YoY
3.20
3.20 – 3.20
-51.5% YoY
5.40
5.40 – 5.40
+68.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C 2/5 1/5 1/5 1/5 2/5 1/5 5/5
2026-05-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-26 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-25 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-6.00M
OE per share TTM
-0.06
Owner's Yield
-0.33%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
136.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
130.8K
Shares Outstanding
108.80M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
V. Srinivasa Rao Whole-Time Chairman & Group Chief Financial Officer 8M male
Vedula Satyanarayana Executive Vice-Chairman & Vice Chairman of Healthcare 7M male
Amar Sivaji Pendyala Chief Executive Officer — male
Kolli Ravindranath Tagore Company Secretary, Chief Investor Relations & Compliance Officer — male
Rajesh Putta Chief Technology Officer — male
Viswanath Kompella IITM Founder & Chairman Emeritus — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Software - Application